CoChat

Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS: We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS: Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of beta-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO2) and beta-oxidation of palmitic acid, whereas EPA increased only beta-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO2 formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS: Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid beta-oxidation; 2) EPA promoted accumulation of TAG, enhanced beta-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-1043

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Palmitate uptake and oxidation. Differentiated myotubes from type 2 diabetic or control subjects were preincubated with 40 μmol/l BSA, 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l EPA for 4 days and incubated with 0.6 mmol/l [1-14C]PA for 4 h. The panels show palmitate uptake, which is the sum of total recovered CO2, ASMs, and total lipids (A); oxidation to CO2 (B); CO2 from palmitic acid as percentage of total oxidation (C). Results present means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data. T2D, type 2 diabetes.
FIG. 1. Palmitate uptake and oxidation. Differentiated myotubes from type 2 diabetic or control subjects were preincubated with 40 μmol/l BSA, 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l EPA for 4 days and incubated with 0.6 mmol/l [1-14C]PA for 4 h. The panels show palmitate uptake, which is the sum of total recovered CO2, ASMs, and total lipids (A); oxidation to CO2 (B); CO2 from palmitic acid as percentage of total oxidation (C). Results present means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data. T2D, type 2 diabetes.CC BY-NC-ND · PubMed Central
FIG. 2. Palmitate-derived ASMs release to the medium. Differentiated myotubes from type 2 diabetes or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with 0.6 mmol/l [1-14C]PA ± 1 μmol/l insulin for 4 h. The panels show ASMs released from the cells, derived from 14C–palmitic acid without (A) and with (B) 1 μmol/l insulin. Results represent means ± SE (n = 6–7). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.
FIG. 2. Palmitate-derived ASMs release to the medium. Differentiated myotubes from type 2 diabetes or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with 0.6 mmol/l [1-14C]PA ± 1 μmol/l insulin for 4 h. The panels show ASMs released from the cells, derived from 14C–palmitic acid without (A) and with (B) 1 μmol/l insulin. Results represent means ± SE (n = 6–7). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.CC BY-NC-ND · PubMed Central
FIG. 3. Changes in TAG accumulation from 14C–palmitic acid relative to baseline (A) and negative correlation between changes in 14C–palmitic acid oxidation and TAG accumulation after preincubation with EPA (B). Differentiated myotubes from type 2 diabetic or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with [1-14C]PA (0.6 mmol/l) for 4 h. The panels show changes in 14C–palmitic acid–derived TAGs as percentage of baseline (BSA) (A) and a negative correlation between changes in total 14C–palmitic acid oxidation and TAG accumulation in myotubes preincubated with EPA (r = −0.69, P < 0.001). Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.
FIG. 3. Changes in TAG accumulation from 14C–palmitic acid relative to baseline (A) and negative correlation between changes in 14C–palmitic acid oxidation and TAG accumulation after preincubation with EPA (B). Differentiated myotubes from type 2 diabetic or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with [1-14C]PA (0.6 mmol/l) for 4 h. The panels show changes in 14C–palmitic acid–derived TAGs as percentage of baseline (BSA) (A) and a negative correlation between changes in total 14C–palmitic acid oxidation and TAG accumulation in myotubes preincubated with EPA (r = −0.69, P < 0.001). Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.CC BY-NC-ND · PubMed Central
FIG. 4. Gene expression of DGAT2 and PGC1α. Panels show changes in DGAT2 (A) and PGC1α (B) gene expression relative to baseline (set to 1) for control and type 2 diabetes myotubes. Cells were preincubated as described in research design and methods. Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.
FIG. 4. Gene expression of DGAT2 and PGC1α. Panels show changes in DGAT2 (A) and PGC1α (B) gene expression relative to baseline (set to 1) for control and type 2 diabetes myotubes. Cells were preincubated as described in research design and methods. Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.CC BY-NC-ND · PubMed Central
FIG. 5. Cellular acyl-CoA relative to baseline. Differentiated myotubes were preincubated as described in Fig. 1 before the cells were harvested for measurement of acyl-CoA. A: shows total acyl-CoA relative to baseline; and B–E: display C16:0-CoA (and TTA-CoA where preincubated with TTA), C16:1-CoA, C18:2-CoA, and C20:4-CoA, respectively. Results represent means ± SE (n = 6–8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. TTA. #P ≤ 0.05 vs. ObControl. Evaluated by nonparametric Mann-Whitney and Wilcoxon's signed-rank test.
FIG. 5. Cellular acyl-CoA relative to baseline. Differentiated myotubes were preincubated as described in Fig. 1 before the cells were harvested for measurement of acyl-CoA. A: shows total acyl-CoA relative to baseline; and B–E: display C16:0-CoA (and TTA-CoA where preincubated with TTA), C16:1-CoA, C18:2-CoA, and C20:4-CoA, respectively. Results represent means ± SE (n = 6–8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. TTA. #P ≤ 0.05 vs. ObControl. Evaluated by nonparametric Mann-Whitney and Wilcoxon's signed-rank test.CC BY-NC-ND · PubMed Central
FIG. 6. Partitioning of de novo synthesized fatty acids in DAG and TAG (A) and effect of TTA on oleic acid–mediated increase in cell-associated 14C–palmitic acid (B). A: Distribution of de novo synthesized 14C-acetate–derived fatty acids after 4 h in complex lipids (DAG and TAG) after 4-day preincubation of human myotubes from healthy donors with 40 μmol/l fatty acid–free BSA (baseline), 100 μmol/l oleic acid, 100 μmol/l EPA, or 100 μmol/l TTA (n = 4). B: Cell-associated 14C–palmitic acid measured by SPA in human myotubes from healthy donors preincubated 4 days with 40 μmol/l BSA (baseline), 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l oleic acid + 100 μmol/l TTA the last day (n = 4). Results represent means ± SE. a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA, analyzed by linear mixed models statistics (SPSS).
FIG. 6. Partitioning of de novo synthesized fatty acids in DAG and TAG (A) and effect of TTA on oleic acid–mediated increase in cell-associated 14C–palmitic acid (B). A: Distribution of de novo synthesized 14C-acetate–derived fatty acids after 4 h in complex lipids (DAG and TAG) after 4-day preincubation of human myotubes from healthy donors with 40 μmol/l fatty acid–free BSA (baseline), 100 μmol/l oleic acid, 100 μmol/l EPA, or 100 μmol/l TTA (n = 4). B: Cell-associated 14C–palmitic acid measured by SPA in human myotubes from healthy donors preincubated 4 days with 40 μmol/l BSA (baseline), 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l oleic acid + 100 μmol/l TTA the last day (n = 4). Results represent means ± SE. a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA, analyzed by linear mixed models statistics (SPSS).CC BY-NC-ND · PubMed Central
FIG. 7. Changes in energy metabolism in human myotubes after preincubation with fatty acids. We observed a reduced oxidative metabolism (CO2 formation) of fatty acids and glucose in obese type 2 diabetes myotubes compared with obese control cells (A vs. B). Incubation with EPA or TTA promoted increased β-oxidation in diabetic cells (C vs. D). EPA enhanced lipid uptake, accumulation of TAG (especially in diabetic cells), and fatty acid β-oxidation in both groups of myotubes (C and D). TTA “normalized” complete lipid oxidation in diabetic myotubes to baseline level in control cells (A and B vs. D) and opposed increased lipid accumulation (C and D). Glucose oxidation was enhanced after chronic exposure to EPA and TTA, reducing nonoxidized glucose (NOG; C and D). NOG consists mostly of lactate and pyruvate. dotted arrows, reduced; fortified arrows, increased; boxes labeled with EPA and TTA, effects of preincubation.
FIG. 7. Changes in energy metabolism in human myotubes after preincubation with fatty acids. We observed a reduced oxidative metabolism (CO2 formation) of fatty acids and glucose in obese type 2 diabetes myotubes compared with obese control cells (A vs. B). Incubation with EPA or TTA promoted increased β-oxidation in diabetic cells (C vs. D). EPA enhanced lipid uptake, accumulation of TAG (especially in diabetic cells), and fatty acid β-oxidation in both groups of myotubes (C and D). TTA “normalized” complete lipid oxidation in diabetic myotubes to baseline level in control cells (A and B vs. D) and opposed increased lipid accumulation (C and D). Glucose oxidation was enhanced after chronic exposure to EPA and TTA, reducing nonoxidized glucose (NOG; C and D). NOG consists mostly of lactate and pyruvate. dotted arrows, reduced; fortified arrows, increased; boxes labeled with EPA and TTA, effects of preincubation.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 73

Metadata

Authors
Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M.
Affiliations
  • University of Oslo (NO)
  • Odense University Hospital (DK)
  • Haukeland University Hospital (NO)
Venue
Diabetes
Published
2009-03-01
Volume
58
Issue
3
Pages
527-535
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2110135879
Cited by
73
References
51
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 4
FWCI
9.22
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
type 2 diabetes, skeletal muscle myotubes, fatty acid beta-oxidation, fatty acid oxidation, eicosapentaenoic acid, tetradecylthioacetic acid, palmitic acid, triglyceride accumulation, mitochondrial dysfunction, glucose oxidation, insulin resistance, acyl-CoA, fatty acid uptake, gene expression
MeSH terms
Uncoupling Protein 2, Fatty Acid Binding Protein 3, Carbon Dioxide, Carbon Radioisotopes, Carnitine O-Palmitoyltransferase, Diabetes Mellitus, Type 2, Fatty Acids, Glucose, Humans, Insulin, Ion Channels, Lipids, Oxidation-Reduction, Reference Values, Sulfides, Eicosapentaenoic Acid, Muscle Fibers, Skeletal, Oleic Acid, Palmitic Acid, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Myoblasts, Fatty Acid-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation. https://app.cochat.ai/papers/10.2337/db08-1043
The paper
Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M. (2009). Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation. Diabetes. https://doi.org/10.2337/db08-1043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.